Lexpos News

/Lexpos News

Medicine Supply Notification: Midazolam (Epistatus® ) 5mg/0.5ml oromucosal solution pre-filled oral syringes

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes. MSN/2024/025 Tier 2 – medium impact Date of issue: 27th February 2024 Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes are currently out of stock. Resupply date of this product is to be [...]

The post Medicine Supply Notification: Midazolam (Epistatus® ) 5mg/0.5ml oromucosal solution pre-filled oral syringes appeared first on Community Pharmacy England.

By |February 27th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Midazolam (Epistatus® ) 5mg/0.5ml oromucosal solution pre-filled oral syringes

Drug Tariff Watch – March 2024

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2024. Contractors should note changes made to Part II – Requirements enabling payments to be made for the supply of drugs, appliances and chemical [...]

The post Drug Tariff Watch – March 2024 appeared first on Community Pharmacy England.

By |February 27th, 2024|Lexpos News|Comments Off on Drug Tariff Watch – March 2024

MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd)

Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) Drug alert number: EL (24)A/07 Date issued: 26 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm [...]

The post MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) appeared first on Community Pharmacy England.

By |February 26th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd)

National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

National Patient Safety Alert: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials National Patient Safety Alert Reference Number: NatPSA/2024/003/DHSC_MVA Date issued: 26 February 2024 Explanation of identified safety issue A Medicines Supply Notification (MSN) issued on 14 February 2024, detailed a shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid. The resolution date [...]

The post National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials appeared first on Community Pharmacy England.

By |February 26th, 2024|Lexpos News|Comments Off on National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

Negotiations on 2024/25 Contractual Framework Commence

Formal tripartite negotiations on the arrangements for the Community Pharmacy Contractual Framework (CPCF) in 2024/25 – the first year following the five-year CPCF deal – have now begun. The negotiations are taking place between Community Pharmacy England and the Department of Health and Social Care (DHSC), supported by NHS England (NHSE). They are beginning ahead [...]

The post Negotiations on 2024/25 Contractual Framework Commence appeared first on Community Pharmacy England.

By |February 23rd, 2024|Lexpos News|Comments Off on Negotiations on 2024/25 Contractual Framework Commence